Info: Read More
  • 中药标准品生产商,产品定制服务
  • 环萜酚酸

    Cannabichromenic acid

    环萜酚酸
    产品编号 CFN91611
    CAS编号 185505-15-1
    分子式 = 分子量 C22H30O4 = 358.47
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Phenols
    植物来源 The herbs of Cannabis sativa.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    环萜酚酸 CFN91611 185505-15-1 1mg QQ客服:3257982914
    环萜酚酸 CFN91611 185505-15-1 5mg QQ客服:3257982914
    环萜酚酸 CFN91611 185505-15-1 10mg QQ客服:3257982914
    环萜酚酸 CFN91611 185505-15-1 20mg QQ客服:3257982914
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • The Australian National University (Australia)
  • Uniwersytet Jagielloński w Krakowie (Poland)
  • Deutsches Krebsforschungszentrum (Germany)
  • Universidad Miguel Hernández (Spain)
  • Celltrion Chemical Research Institute (Korea)
  • Tokyo Woman's Christian University (Japan)
  • Lodz University of Technology (Poland)
  • Northeast Normal University Changchun (China)
  • Cancer Research Initatives Foundation(CARIF) (Malaysia)
  • University of Eastern Finland (Finland)
  • University of Madras (India)
  • Tohoku University (Japan)
  • National Hellenic Research Foundation (Greece)
  • Periyar University (India)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Sci Rep.2021, 11(1):10931.
  • Int J Mol Sci.2018, 19(9):E2601
  • Pharm Biol.2016, 54(7):1255-62
  • Exp Ther Med.2019, 18(6):4388-4396
  • Pharmacognosy Journal.2020, 12(2), p232-235.
  • J of L. Chroma.&Related Tech2017, 252-258
  • Anticancer Res.2018, 38(4):2127-2135
  • Pharm Biol.2017, 55(1):360-366
  • Anticancer Res.2022, 42(9):4403-4410.
  • Legume Science2021, 3(4): e101.
  • Trop J Nat Prod Res.2019, 3(1):6-9
  • J Ethnopharmacol.2021, 267:113615.
  • J Ethnopharmacol.2024, 320:117426.
  • Kor. J. Herbol.2022, 37(5): 89-96.
  • Life (Basel).2022, 12(10):1630.
  • VNU Journal of Science2023, No. 20.
  • Int J Mol Sci.2022, 23(15):8687.
  • Evid Based Complement Alternat Med.2020, 2020:2584783.
  • Front Plant Sci.2021, 12: 648426.
  • Korean Journal of Pharmacognosy.2019, 50(1):65-71
  • J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1126-1127:121743
  • JEJU National University2022, 24032.
  • Free Radic Biol Med.2016, 97:307-319
  • ...
  • 生物活性
    Description: Cannabichromenic acid is a new antibiotic active against gram-positive bacteria, including MRSA.
    In vitro:
    Antibiotics (Basel) . 2020 Aug 16;9(8):523.
    Rapid Antibacterial Activity of Cannabichromenic Acid against Methicillin-Resistant Staphylococcus aureus[Pubmed: 32824356]
    Methicillin-resistant Staphylococcus aureus (MRSA) has proven to be an imminent threat to public health, intensifying the need for novel therapeutics. Previous evidence suggests that cannabinoids harbour potent antibacterial activity. In this study, a group of previously inaccessible phytocannabinoids and synthetic analogues were examined for potential antibacterial activity. The minimum inhibitory concentrations and dynamics of bacterial inhibition, determined through resazurin reduction and time-kill assays, revealed the potent antibacterial activity of the phytocannabinoids against gram-positive antibiotic-resistant bacterial species, including MRSA. One phytocannabinoid, cannabichromenic acid (CBCA), demonstrated faster and more potent bactericidal activity than vancomycin, the currently recommended antibiotic for the treatment of MRSA infections. Such bactericidal activity was sustained against low-and high-dose inoculums as well as exponential- and stationary-phase MRSA cells. Further, mammalian cell viability was maintained in the presence of CBCA. Finally, microscopic evaluation suggests that CBCA may function through the degradation of the bacterial lipid membrane and alteration of the bacterial nucleoid. The results of the current study provide encouraging evidence that cannabinoids may serve as a previously unrecognised resource for the generation of novel antibiotics active against MRSA.
    In vivo:
    J Nat Prod. 2019 Nov 22;82(11):3047-3055.
    Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome[Pubmed: 31686510]
    Cannabis sativa produces a complex mixture of many bioactive molecules including terpenophenolic compounds known as phytocannabinoids. Phytocannabinoids come in neutral forms (e.g., Δ9-tetrahydrocannabinol, THC; cannabidiol, CBD; etc.) or as acid precursors, which are dominant in the plant (e.g., Δ9-tetrahydrocannabinolic acid, THCA; cannabidiolic acid, CBDA; etc.). There is increasing interest in unlocking the therapeutic applications of the phytocannabinoid acids; however, the present understanding of the basic pharmacology of phytocannabinoid acids is limited. Herein the brain and plasma pharmacokinetic profiles of CBDA, THCA, cannabichromenic acid (CBCA), cannabidivarinic acid (CBDVA), cannabigerolic acid (CBGA), and cannabigerovarinic acid (CBGVA) were examined following intraperitoneal administration in mice. Next it was examined whether CBDA was anticonvulsant in a mouse model of Dravet syndrome (Scn1aRX/+ mice). All the phytocannabinoid acids investigated were rapidly absorbed with plasma tmax values of between 15 and 45 min and had relatively short half-lives (<4 h). The brain-plasma ratios for the acids were very low at ≤0.04. However, when CBDA was administered in an alternate Tween 80-based vehicle, it exhibited a brain-plasma ratio of 1.9. The anticonvulsant potential of CBDA was examined using this vehicle, and it was found that CBDA significantly increased the temperature threshold at which the Scn1aRX/+ mice had a generalized tonic-clonic seizure.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.7896 mL 13.9482 mL 27.8963 mL 55.7927 mL 69.7408 mL
    5 mM 0.5579 mL 2.7896 mL 5.5793 mL 11.1585 mL 13.9482 mL
    10 mM 0.279 mL 1.3948 mL 2.7896 mL 5.5793 mL 6.9741 mL
    50 mM 0.0558 mL 0.279 mL 0.5579 mL 1.1159 mL 1.3948 mL
    100 mM 0.0279 mL 0.1395 mL 0.279 mL 0.5579 mL 0.6974 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    大麻色原烯; Cannabichromene CFN98039 20675-51-8 C21H30O2 = 314.5 5mg QQ客服:2056216494
    次色酚酸; Cannabichromevarinic acid CFN91609 64898-02-8 C20H26O4 = 330.42 5mg QQ客服:1413575084
    环萜酚酸; Cannabichromenic acid CFN91611 185505-15-1 C22H30O4 = 358.47 5mg QQ客服:1413575084
    茅术色烯; Atractylochromene CFN95162 203443-33-8 C17H22O2 = 258.4 10mg QQ客服:3257982914
    Denudaquinol; Denudaquinol CFN91935 1189105-40-5 C19H26O4 = 318.41 5mg QQ客服:2056216494
    4-羟基-3,5-双(3-甲基-2-丁烯-1-基)苯甲酸; Nervogenic acid CFN99828 17622-86-5 C17H22O3 = 274.4 5mg QQ客服:2056216494
    4-羟基-3-(3-甲基-2-丁烯酰基)-5-(3-甲基-2-丁烯基)苯甲酸; 4-Hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)benzoic acid CFN99652 155051-85-7 C17H20O4 = 288.3 5mg QQ客服:2159513211
    2,2-二甲基-8-(3-甲基-2-丁烯基)-2H-苯并吡喃-6-羧酸; 2,2-Dimethyl-8-prenylchromene 6-carboxylic acid CFN99633 151731-50-9 C17H20O3 = 272.3 5mg QQ客服:2056216494
    次萜酚酸; Cannabigerovarinic acid CFN91610 64924-07-8 C20H28O4 = 332.43 5mg QQ客服:2056216494
    大麻萜酚; Cannabigerol CFN98287 25654-31-3 C21H32O2 = 316.5 10mg QQ客服:1413575084

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产